DE60315664D1 - Verfahren zur herstellung von 5-(1,3-oxazol-2-yl)benzoesäurederivaten - Google Patents
Verfahren zur herstellung von 5-(1,3-oxazol-2-yl)benzoesäurederivatenInfo
- Publication number
- DE60315664D1 DE60315664D1 DE60315664T DE60315664T DE60315664D1 DE 60315664 D1 DE60315664 D1 DE 60315664D1 DE 60315664 T DE60315664 T DE 60315664T DE 60315664 T DE60315664 T DE 60315664T DE 60315664 D1 DE60315664 D1 DE 60315664D1
- Authority
- DE
- Germany
- Prior art keywords
- sub
- oxazol
- preparing
- benzoic acid
- acid derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39028502P | 2002-06-20 | 2002-06-20 | |
| US45047803P | 2003-02-27 | 2003-02-27 | |
| PCT/US2003/019585 WO2004000821A1 (en) | 2002-06-20 | 2003-06-20 | Process for preparing 5-(1, 3-oxazol-2-yl) benzoic acid derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60315664D1 true DE60315664D1 (de) | 2007-09-27 |
Family
ID=30003150
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60315664T Expired - Lifetime DE60315664D1 (de) | 2002-06-20 | 2003-06-20 | Verfahren zur herstellung von 5-(1,3-oxazol-2-yl)benzoesäurederivaten |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US7115747B2 (de) |
| EP (1) | EP1532123B1 (de) |
| JP (1) | JP2005533811A (de) |
| CN (1) | CN1324017C (de) |
| AT (1) | ATE370131T1 (de) |
| AU (1) | AU2003249344A1 (de) |
| BR (1) | BR0312439A (de) |
| CA (1) | CA2489988A1 (de) |
| CO (1) | CO5670350A2 (de) |
| DE (1) | DE60315664D1 (de) |
| EA (1) | EA008389B1 (de) |
| HK (1) | HK1081543A1 (de) |
| IL (1) | IL165763A0 (de) |
| MX (1) | MXPA04012630A (de) |
| NO (1) | NO20045497L (de) |
| NZ (1) | NZ537390A (de) |
| PL (1) | PL374999A1 (de) |
| WO (1) | WO2004000821A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20040762A1 (es) * | 2002-11-27 | 2004-11-06 | Elan Pharm Inc | Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer |
| TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| US7745484B2 (en) | 2005-11-21 | 2010-06-29 | Amgen Inc. | Beta-secretase modulators and methods of use |
| EP1971598A1 (de) | 2005-11-21 | 2008-09-24 | Amgen Inc. | Beta-sekretase-modulatoren und anwendungsverfahren |
| US7838676B2 (en) * | 2005-11-21 | 2010-11-23 | Amgen Inc. | Beta-secretase modulators and methods of use |
| US7872009B2 (en) * | 2005-11-21 | 2011-01-18 | Amgen Inc. | Beta-Secretase modulators and methods of use |
| WO2008137168A2 (en) * | 2007-05-07 | 2008-11-13 | True Charles W | Collapsible, stackable, semi-rigid universal tank for hazardous and non-hazardous goods |
| US8163909B2 (en) | 2007-05-25 | 2012-04-24 | Amgen Inc. | Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| EP2167471B1 (de) | 2007-05-25 | 2013-10-16 | Amgen Inc. | Substituierte hydroxyethylaminverbindungen als modulatoren von beta-sekretase und anwendungsverfahren |
| US7803809B2 (en) | 2008-11-12 | 2010-09-28 | Amgen Inc. | Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use |
| EA201100461A1 (ru) | 2008-09-11 | 2011-10-31 | Амген Инк. | Спиро-трициклические соединения как модуляторы бета-секретазы и способы их использования |
| WO2011063233A1 (en) | 2009-11-23 | 2011-05-26 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| US8822485B2 (en) | 2009-11-23 | 2014-09-02 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| WO2011090911A1 (en) | 2010-01-19 | 2011-07-28 | Amgen Inc. | Amino heteroaryl compounds as beta-secretase modulators and methods of use |
| US8497264B2 (en) | 2010-03-15 | 2013-07-30 | Amgen Inc. | Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US8883782B2 (en) | 2010-03-15 | 2014-11-11 | Amgen Inc. | Spiro-tetracyclic ring compounds as beta-secretase modulators and methods of use |
| US9346827B2 (en) | 2011-02-07 | 2016-05-24 | Amgen Inc. | 5-amino-oxazepine and 5-amino-thiazepane compounds as beta secretase antagonists and methods of use |
| EP2758406A1 (de) | 2011-09-21 | 2014-07-30 | Amgen Inc. | Amino-oxazine und amino-dihydrothiazinverbindungen als beta-sekretase-modulatoren und verwendungsverfahren dafür |
| WO2014078314A1 (en) | 2012-11-15 | 2014-05-22 | Amgen Inc. | Amino-oxazine and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| US11272751B2 (en) | 2016-03-01 | 2022-03-15 | Nicholas Popejoy | Protective headgear, impact diffusing systems and methods |
| US9462841B1 (en) | 2016-03-01 | 2016-10-11 | William Popejoy | Protective headgear and shoulder pad apparatus and methods |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20020276A1 (es) * | 2000-06-30 | 2002-04-06 | Elan Pharm Inc | COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER |
| EP1432674A2 (de) | 2001-10-04 | 2004-06-30 | Elan Pharmaceuticals, Inc. | Hydroxypropylamine |
| AP2004003049A0 (en) | 2001-11-08 | 2004-06-30 | Elan Pharm Inc | N,N' -substituted-1,3-diamino -2-hydroxypropane derivatives. |
| GB0325830D0 (en) * | 2003-11-05 | 2003-12-10 | Novartis Ag | Organic compounds |
-
2003
- 2003-06-20 DE DE60315664T patent/DE60315664D1/de not_active Expired - Lifetime
- 2003-06-20 AU AU2003249344A patent/AU2003249344A1/en not_active Abandoned
- 2003-06-20 WO PCT/US2003/019585 patent/WO2004000821A1/en active IP Right Grant
- 2003-06-20 EA EA200401510A patent/EA008389B1/ru unknown
- 2003-06-20 US US10/600,100 patent/US7115747B2/en not_active Expired - Fee Related
- 2003-06-20 AT AT03761206T patent/ATE370131T1/de not_active IP Right Cessation
- 2003-06-20 MX MXPA04012630A patent/MXPA04012630A/es active IP Right Grant
- 2003-06-20 JP JP2004516055A patent/JP2005533811A/ja active Pending
- 2003-06-20 CA CA002489988A patent/CA2489988A1/en not_active Abandoned
- 2003-06-20 NZ NZ537390A patent/NZ537390A/en unknown
- 2003-06-20 BR BR0312439-8A patent/BR0312439A/pt not_active IP Right Cessation
- 2003-06-20 PL PL03374999A patent/PL374999A1/xx unknown
- 2003-06-20 EP EP03761206A patent/EP1532123B1/de not_active Expired - Lifetime
- 2003-06-20 CN CNB038144476A patent/CN1324017C/zh not_active Expired - Fee Related
-
2004
- 2004-12-14 IL IL16576304A patent/IL165763A0/xx unknown
- 2004-12-16 NO NO20045497A patent/NO20045497L/no not_active Application Discontinuation
-
2005
- 2005-01-20 CO CO05004558A patent/CO5670350A2/es not_active Application Discontinuation
-
2006
- 2006-02-07 HK HK06101593A patent/HK1081543A1/xx not_active IP Right Cessation
- 2006-10-03 US US11/538,155 patent/US20070105921A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| HK1081543A1 (en) | 2006-05-19 |
| WO2004000821A1 (en) | 2003-12-31 |
| IL165763A0 (en) | 2006-01-15 |
| US20040063965A1 (en) | 2004-04-01 |
| EA008389B1 (ru) | 2007-04-27 |
| EP1532123B1 (de) | 2007-08-15 |
| MXPA04012630A (es) | 2005-09-30 |
| CN1324017C (zh) | 2007-07-04 |
| CO5670350A2 (es) | 2006-08-31 |
| BR0312439A (pt) | 2005-05-10 |
| CN1662510A (zh) | 2005-08-31 |
| NZ537390A (en) | 2006-07-28 |
| NO20045497D0 (no) | 2004-12-16 |
| US7115747B2 (en) | 2006-10-03 |
| US20070105921A1 (en) | 2007-05-10 |
| CA2489988A1 (en) | 2003-12-31 |
| NO20045497L (no) | 2005-03-07 |
| EA200401510A1 (ru) | 2005-06-30 |
| EP1532123A1 (de) | 2005-05-25 |
| AU2003249344A1 (en) | 2004-01-06 |
| ATE370131T1 (de) | 2007-09-15 |
| JP2005533811A (ja) | 2005-11-10 |
| PL374999A1 (en) | 2005-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60315664D1 (de) | Verfahren zur herstellung von 5-(1,3-oxazol-2-yl)benzoesäurederivaten | |
| DE60336867D1 (de) | Verfahren zur Herstellung von 3-Halo-4,5-Dihydro-1H-Pyrazolen | |
| ATE533775T1 (de) | Verfahren zur herstellung von 17-vinyl-triflaten als intermediate | |
| ATE348814T1 (de) | Verfahren zur herstellung von chinolinderivaten | |
| ATE404637T1 (de) | Verbessertes verfahren und methode zur herstellung von asymmetrischen monofunktionalisierten indocyaninmarkern sowie erhaltene verbindungen | |
| DE602006021411D1 (de) | Verfahren zur herstellung von optional 2-substituierten 1,6-dihydro-6-oxo-4-pyrimidincarboxylsäuren | |
| ATE331713T1 (de) | Verfahren zur herstellung von 5-nitrobenzofuranen | |
| ATE441627T1 (de) | Verfahren zur herstellung von valsartan | |
| DE602004011255D1 (de) | Phosphinsäurederivate, inhibitoren von beta-sekretase zur behandlung von alzheimer-krankheit | |
| DE502005008867D1 (de) | Verfahren zur herstellung von 2,5-dimethylphenylessigsäure | |
| ATE437855T1 (de) | (4,5,6,7-tetrahydro-1h-indol-7- yl)essigsäurederivate zur behandlung von alzheimer-krankheit | |
| DE502004004970D1 (de) | Verfahren zur herstellung von oh-geschützten ä4-(2,6-diamino-9h-purin-9-yl)-1,3-dioxolan-2-ylümethanol-derivaten | |
| ATE531702T1 (de) | Verfahren zur herstellung von epoxytriazolderivat und zwischenprodukten dafür | |
| ATE496907T1 (de) | Verfahren zur herstellung von cilostazol | |
| ATE415404T1 (de) | Lösungsmittelfreies verfahren zur herstellung von diketopyrrolopyrrol-derivaten | |
| ATE348811T1 (de) | Verfahren zur herstellung von 2- aminomethylpyridin-derivaten | |
| ATE282594T1 (de) | Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin | |
| DE60133395D1 (de) | Verfahren zur herstellung von alpha'-chlorketonen | |
| DE602005022213D1 (de) | Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| ATE380183T1 (de) | Verfahren zur herstellung von phenyltetrazolderivaten | |
| ATE330612T1 (de) | Verfahren zur herstellung von benazeprilhydrochloride | |
| WO2004032854A3 (en) | Pharmaceutical compositions for treatment of parkinson's disease | |
| ATE223377T1 (de) | Verfahren zur herstellung von difluoracetophenon- derivaten | |
| ATE339401T1 (de) | Verfahren zur herstellung von alpha-(3-arylthio)- acetophenonen | |
| DE60225338D1 (de) | Verfahren zur herstellung von derivaten von 3,3-dimethyl-2-formylcyclopropanekarbonsäure |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |